Phosphatidylserine expression on cell surfaces promotes antibody-dependent aggregation and thrombosis in β2-glycoprotein I-immune mice

Derek Dombroski, Krishnakumar Balasubramanian, Alan J. Schroit

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

Beta-2-glycoprotein I (β2GP1) has been implicated as the primary antigenic target in antiphospholipid syndrome. To study the role β2GP1 antibodies play in thrombosis associated with this syndrome, the clearance and binding of phosphatidylserine (PS)-containing target membranes were monitored in β2GP1-immune mice. Clearance in immune mice (T(1/2)4.8 min) was faster than in normal mice (T(1/2) 11.0 min). Analysis of PS vesicles recovered from immune mice by sequencing and Western blotting showed the presence of bound β2GP1 and autologous antibody, respectively. Bleeding times in immune mice were ~30% shorter than in control mice. In vitro clotting times, however, were the same in both populations. To determine if the in vivo results could be attributed to the interaction of autoantibodies with the vascular endothelium, the binding of PS-containing target membranes to normal and apoptotic endothelial cells was studied. While endothelial cells bound PS vesicles, β2GP1 reduced uptake by ~50% in both normal and apoptotic endothelium. In the presence of β2GP1 antibodies, however, uptake in apoptotic cells, but not normal cells, increased by more than two-fold. These results suggest that thrombosis in antiphospholipid syndrome could, in part, be due to antibody-dependent cross-linking of β2GP1 bound to PS-expressing cells and the vascular endothelium. (C) 2000 Academic Press.

Original languageEnglish (US)
Pages (from-to)221-229
Number of pages9
JournalJournal of Autoimmunity
Volume14
Issue number3
DOIs
StatePublished - 2000

Fingerprint

Phosphatidylserines
Glycoproteins
Thrombosis
Antibodies
Antiphospholipid Syndrome
Vascular Endothelium
Endothelial Cells
beta 2-Glycoprotein I
Bleeding Time
Membranes
Autoantibodies
Endothelium
Western Blotting
Population

Keywords

  • Antiphospholipid syndrome
  • Apoptosis
  • Beta-2-glycoprotein I
  • Phosphatidylserine
  • Thrombosis

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

Phosphatidylserine expression on cell surfaces promotes antibody-dependent aggregation and thrombosis in β2-glycoprotein I-immune mice. / Dombroski, Derek; Balasubramanian, Krishnakumar; Schroit, Alan J.

In: Journal of Autoimmunity, Vol. 14, No. 3, 2000, p. 221-229.

Research output: Contribution to journalArticle

@article{881bbb1578294a6099b796d67bfe0fbf,
title = "Phosphatidylserine expression on cell surfaces promotes antibody-dependent aggregation and thrombosis in β2-glycoprotein I-immune mice",
abstract = "Beta-2-glycoprotein I (β2GP1) has been implicated as the primary antigenic target in antiphospholipid syndrome. To study the role β2GP1 antibodies play in thrombosis associated with this syndrome, the clearance and binding of phosphatidylserine (PS)-containing target membranes were monitored in β2GP1-immune mice. Clearance in immune mice (T(1/2)4.8 min) was faster than in normal mice (T(1/2) 11.0 min). Analysis of PS vesicles recovered from immune mice by sequencing and Western blotting showed the presence of bound β2GP1 and autologous antibody, respectively. Bleeding times in immune mice were ~30{\%} shorter than in control mice. In vitro clotting times, however, were the same in both populations. To determine if the in vivo results could be attributed to the interaction of autoantibodies with the vascular endothelium, the binding of PS-containing target membranes to normal and apoptotic endothelial cells was studied. While endothelial cells bound PS vesicles, β2GP1 reduced uptake by ~50{\%} in both normal and apoptotic endothelium. In the presence of β2GP1 antibodies, however, uptake in apoptotic cells, but not normal cells, increased by more than two-fold. These results suggest that thrombosis in antiphospholipid syndrome could, in part, be due to antibody-dependent cross-linking of β2GP1 bound to PS-expressing cells and the vascular endothelium. (C) 2000 Academic Press.",
keywords = "Antiphospholipid syndrome, Apoptosis, Beta-2-glycoprotein I, Phosphatidylserine, Thrombosis",
author = "Derek Dombroski and Krishnakumar Balasubramanian and Schroit, {Alan J.}",
year = "2000",
doi = "10.1006/jaut.2000.0365",
language = "English (US)",
volume = "14",
pages = "221--229",
journal = "Journal of Autoimmunity",
issn = "0896-8411",
publisher = "Academic Press Inc.",
number = "3",

}

TY - JOUR

T1 - Phosphatidylserine expression on cell surfaces promotes antibody-dependent aggregation and thrombosis in β2-glycoprotein I-immune mice

AU - Dombroski, Derek

AU - Balasubramanian, Krishnakumar

AU - Schroit, Alan J.

PY - 2000

Y1 - 2000

N2 - Beta-2-glycoprotein I (β2GP1) has been implicated as the primary antigenic target in antiphospholipid syndrome. To study the role β2GP1 antibodies play in thrombosis associated with this syndrome, the clearance and binding of phosphatidylserine (PS)-containing target membranes were monitored in β2GP1-immune mice. Clearance in immune mice (T(1/2)4.8 min) was faster than in normal mice (T(1/2) 11.0 min). Analysis of PS vesicles recovered from immune mice by sequencing and Western blotting showed the presence of bound β2GP1 and autologous antibody, respectively. Bleeding times in immune mice were ~30% shorter than in control mice. In vitro clotting times, however, were the same in both populations. To determine if the in vivo results could be attributed to the interaction of autoantibodies with the vascular endothelium, the binding of PS-containing target membranes to normal and apoptotic endothelial cells was studied. While endothelial cells bound PS vesicles, β2GP1 reduced uptake by ~50% in both normal and apoptotic endothelium. In the presence of β2GP1 antibodies, however, uptake in apoptotic cells, but not normal cells, increased by more than two-fold. These results suggest that thrombosis in antiphospholipid syndrome could, in part, be due to antibody-dependent cross-linking of β2GP1 bound to PS-expressing cells and the vascular endothelium. (C) 2000 Academic Press.

AB - Beta-2-glycoprotein I (β2GP1) has been implicated as the primary antigenic target in antiphospholipid syndrome. To study the role β2GP1 antibodies play in thrombosis associated with this syndrome, the clearance and binding of phosphatidylserine (PS)-containing target membranes were monitored in β2GP1-immune mice. Clearance in immune mice (T(1/2)4.8 min) was faster than in normal mice (T(1/2) 11.0 min). Analysis of PS vesicles recovered from immune mice by sequencing and Western blotting showed the presence of bound β2GP1 and autologous antibody, respectively. Bleeding times in immune mice were ~30% shorter than in control mice. In vitro clotting times, however, were the same in both populations. To determine if the in vivo results could be attributed to the interaction of autoantibodies with the vascular endothelium, the binding of PS-containing target membranes to normal and apoptotic endothelial cells was studied. While endothelial cells bound PS vesicles, β2GP1 reduced uptake by ~50% in both normal and apoptotic endothelium. In the presence of β2GP1 antibodies, however, uptake in apoptotic cells, but not normal cells, increased by more than two-fold. These results suggest that thrombosis in antiphospholipid syndrome could, in part, be due to antibody-dependent cross-linking of β2GP1 bound to PS-expressing cells and the vascular endothelium. (C) 2000 Academic Press.

KW - Antiphospholipid syndrome

KW - Apoptosis

KW - Beta-2-glycoprotein I

KW - Phosphatidylserine

KW - Thrombosis

UR - http://www.scopus.com/inward/record.url?scp=0033856205&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033856205&partnerID=8YFLogxK

U2 - 10.1006/jaut.2000.0365

DO - 10.1006/jaut.2000.0365

M3 - Article

VL - 14

SP - 221

EP - 229

JO - Journal of Autoimmunity

JF - Journal of Autoimmunity

SN - 0896-8411

IS - 3

ER -